Tag results:

Industry & Policy News

Viral Hepatitis Is a Silent Killer. It Can’t Be Eliminated If It Isn’t Tracked

[Stat] By all accounts, the US should be able to eliminate viral hepatitis, but instead new cases are on the rise, largely due to the opioid epidemic and increasing viral hepatitis transmission through injection drug use.

Hudson Institute Bolsters Inflammation Research with New Hires

[Hudson Institute of Medical Research (Mirage News)] Director and CEO Professor Elizabeth Hartland announced that Professor Carl Walkley and Dr Sophia Davidson will join the Institute's Centre for Innate Immunity and Infectious Diseases (CiiiD) as Research Group Heads, bringing impressive resumés and exciting research opportunities with them.

Professor Graham Ogg Receives Wellcome Discovery Award with International Team

[Radcliffe Department of Medicine] A team led by Professor Graham Ogg, Deputy Director of the MRC Translational Immune Discovery Unit and Leader of the Translational Dermatology Unit, alongside Professor Jamie Rossjohn, Professor Branch Moody, Professor Muzlifah Haniffa, and Professor Gurdyal Besra, have received a Wellcome Discovery Award to investigate how immune cells contribute to inflammation.

A New Hope for Men with Metastatic Prostate Cancer

[McGill University Health Centre] The Research Institute of McGill University Health Centre has enrolled the first patients to take part in an early-stage, multi-centre clinical trial of Actinium-225, a radioactive isotope used as a treatment for metastatic prostate cancer.

Uq Researcher Dr Kevin Koo Awarded Prostate Cancer Foundation of Australia Research Grant

[The University of Queensland] Dr Kevin Koo, from The University of Queensland’s (UQ) Centre for Clinical Research, has been awarded one of five new research grants worth a combined value of $1.2 million from the Prostate Cancer Foundation of Australia.

Global Breast Cancer Report Finds Inequities Persist

[National Institute for Health and Care Research] A new Lancet Commission sets out recommendations to tackle urgent global challenges in breast cancer. Supported by the National Institute for Health and Care Research, the commission reveals that despite significant improvements inequities persist.